Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
J Viral Hepat. 2010 Oct;17(10):720-9. doi: 10.1111/j.1365-2893.2009.01232.x.
Up to 10% of all patients with Hepatitis C virus (HCV) infection are co-infected with human immunodeficiency virus (HIV); 25-30% of HIV patients are co-infected with HCV. The aim of this study was to examine the association of HCV/HIV co-infection with outcomes of hospitalized patients compared to those with HCV or HIV monoinfection. Using the 2006 Nationwide Inpatient Sample, patients with HCV or HIV monoinfection or HCV/HIV co-infection were identified using ICD-9-CM codes. We compared liver-related and infection-related admission between the three groups of patients. Multivariate logistic regression was performed to identify independent predictors of in-hospital mortality. A total of 474,843 discharges with HCV monoinfection, 206,758 with HIV monoinfection and 56,304 with HCV/HIV co-infection were included. Liver-related admissions were more common in co-infected patients (15.4%) compared to those with HIV monoinfection (3.3%, P < 0.001). Primary infectious hospitalizations were more common in HIV monoinfection (33.9%) compared to co-infected patients (26%, P < 0.001). HCV/HIV co-infection was associated with higher mortality compared to HCV monoinfection (OR 1.41, 95% CI 1.20-1.65) but not when compared to monoinfected-HIV patients. HCV-associated cirrhosis or complications thereof conferred four times greater mortality risk in patients with HIV (OR 3.96, 95% CI 3.29-4.79). The rate of hospitalization for HCV/HIV co-infected patients (23.5%) was significantly higher than those with HCV (14.8%) or HIV (19.9%) (P < 0.001). HCV/HIV co-infection is associated with significantly higher rates of hospitalization and is a risk factor for in-hospital mortality compared to patients with isolated HCV.
高达 10%的丙型肝炎病毒 (HCV) 感染者合并感染人类免疫缺陷病毒 (HIV);25-30%的 HIV 患者合并感染 HCV。本研究旨在检查 HCV/HIV 合并感染与住院患者结局的相关性,与 HCV 或 HIV 单一感染患者进行比较。使用 2006 年全国住院患者样本,通过国际疾病分类第 9 版临床修订码 (ICD-9-CM) 代码确定 HCV 或 HIV 单一感染或 HCV/HIV 合并感染的患者。我们比较了三组患者的肝相关和感染相关入院情况。采用多变量逻辑回归分析确定住院死亡率的独立预测因素。共纳入 474843 例 HCV 单一感染、206758 例 HIV 单一感染和 56304 例 HCV/HIV 合并感染的出院患者。合并感染患者的肝相关住院率(15.4%)高于 HIV 单一感染患者(3.3%,P<0.001)。原发性感染性住院率在 HIV 单一感染患者中更为常见(33.9%),高于合并感染患者(26%,P<0.001)。与 HCV 单一感染相比,HCV/HIV 合并感染与死亡率升高相关(OR 1.41,95%CI 1.20-1.65),但与 HIV 单一感染患者相比则不然。HIV 感染者合并 HCV 相关性肝硬化或其并发症使死亡率增加四倍(OR 3.96,95%CI 3.29-4.79)。HCV/HIV 合并感染患者的住院率(23.5%)明显高于 HCV(14.8%)或 HIV(19.9%)(P<0.001)。HCV/HIV 合并感染与更高的住院率显著相关,与单独感染 HCV 的患者相比,是住院死亡率的危险因素。